Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.

Journal of the American Society of Nephrology : JASN
S OikawaJ Sasaki

Abstract

Lipoprotein glomerulopathy (LPG) is a novel disease characterized by proteinuria, lipoprotein thrombi in the glomeruli, and increased concentration of plasma apolipoprotein (apo) E. It is believed that a genetic disorder of apo E may be present and associated with the disease. Three patients with LPG were examined in this study. The patients' DNA sequences were analyzed, and a nucleotide G to C point mutation in exon 4 of the apo E gene was confirmed in each patient. This missense mutation denotes amino acid substitution of the proline residue for arginine residue at position 145 of apo E. This variant (apo E Sendai) may cause a marked molecular conformational change of the apo E. These findings suggest that a novel variant is etiologically related to LPG.

Citations

May 1, 2002·Current Opinion in Nephrology and Hypertension·Meena Sahadevan, Bertram L Kasiske
Jul 15, 1999·Journal of the American Society of Nephrology : JASN·T MiyataK Kurokawa
Jul 21, 1999·Kidney International. Supplement·T SaitoJ Sasaki
Mar 6, 2021·Journal of Translational Medicine·Hongyan WuZhangxue Hu
Feb 22, 2001·Journal of the American Society of Nephrology : JASN·Michael M HoffmannWinfried März
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Norio IeiriYoshio Taguma
Mar 13, 2003·Kidney International·Maurizio BruschiGian Marco Ghiggeri
Jul 17, 2003·European Journal of Clinical Investigation·A R MiserezM M Hoffmann
Sep 5, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Chao-Fu ChangWu-Chang Yang
Jun 1, 2021·Atherosclerosis·Yara Abou KhalilMathilde Varret
Jun 3, 2021·International Journal of Molecular Sciences·Meewhi Kim, Ilya Bezprozvanny
Jan 30, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Evagelos LiberopoulosMoses Elisaf
Aug 30, 2008·Kidney International·Huiping ChenLeishi Li
Feb 4, 2014·Kidney International·Takao Saito, Akira Matsunaga
Oct 24, 1998·Endocrinology and Metabolism Clinics of North America·J Davignon, J Genest
Jul 28, 2021·Diagnostic Pathology·Joaquim Nelito da Silveira-NetoLuiz Fernando Onuchic
Mar 1, 1997·The Tohoku Journal of Experimental Medicine·T Saito
Jan 25, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Takao SaitoShinichi Oikawa
Feb 24, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ramin SamAshok K Singh
Mar 6, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mikito HayakawaAkira Yamada
Oct 14, 2006·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Takao Saito
Apr 6, 2011·Current Opinion in Lipidology·Vasilis Tsimihodimos, Moses Elisaf
May 22, 2009·Clinical and Experimental Nephrology·Atsunori IshimuraTakao Saito
Jul 16, 2009·Clinical and Experimental Nephrology·Akira MatsunagaKiyoshi Hayasaka
Jul 14, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andrew S BombackBrad H Rovin
Jul 17, 2004·Journal of Atherosclerosis and Thrombosis·Takao MaruyamaUNKNOWN Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan
Jun 15, 2011·Journal of Atherosclerosis and Thrombosis·Takao Saito, Akira Matsunaga
Feb 18, 2011·Journal of Atherosclerosis and Thrombosis·Asuka MitaniTaku Yamamura
Apr 7, 2011·Journal of Atherosclerosis and Thrombosis·Takehiko TokuraNaoki Kashihara

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.